Lupin Gets Nod From USFDA To Market Type 2 Diabetes
Drug firm Lupin has received tentative nod from the US health regulator to market generic Empagliflozin and Linagliptin tablets, used as an adjunct to diet and exercise to improve glycemic…
Share